Seroprevalence of herpes simplex virus type 1 and type 2 in Turkey

AbstractBackground  Herpes simplex virus (HSV) infections are among the most common infectious diseases in humans. The prevalence of herpes simplex viruses type 1 (HSV‐1) and type 2 (HSV‐2) varies widely across the world. HSV‐2 infection is the primary cause of genital herpes. It is highly prevalent in human populations in many parts of the world, and is the most common cause of genital ulcer disease worldwide. In spite of the large prevalence and growing incidence of herpes simplex infection (HSV‐1 and HSV‐2), relatively few data have been published regarding the seroprevalence of herpes simplex infection, while no data exist regarding the Turkish population.Methods  We aimed to investigate the prevalence of HSV‐1 and HSV‐2 in selected populations in Turkey. A cross‐sectional study was conducted involving 2082 serum samples of 725 adults, 300 pregnant women, 200 blood donors, 483 sex workers and 110 patients with genital warts and 264 hotel staff in Istanbul, Turkey. All serum samples were assessed for HSV1 and HSV‐2 IgG antibodies using an HSV‐type specific, enzyme‐linked immunosorbent assay (ELISA).Results  The prevalence of HSV‐2 and HSV‐1 antibodies was 4.8 and 85.3% in sexually active adults; 5.5 and 96% in blood donors; 5 and 98% in pregnant women, 17.3 and 93.6% in patients with genital warts; 8.3 and 97.3% in hotel staff; and 60% and 99% in sex workers.Conclusion  These results confirm a higher prevalence of HSV infection than estimated, especially in high risk groups in Turkey. The high prevalence of HSV infection underlines the need for education among these populations.